Chen Wei-Liang, Yuan Zhi-Qiang, Liu Yang, Yang Shu-di, Zhang Chun-ge, Li Ji-Zhao, Zhu Wen-jing, Li Fang, Zhou Xiao-feng, Lin Yi-mei, Zhang Xue-nong
Department of Pharmaceutics, College of Pharmaceutical Sciences, Soochow University, Suzhou, People's Republic of China.
Department of Radiobiology, College of Radiological Medicine and Protection, Soochow University, Suzhou, People's Republic of China; Changshu Hospital of Traditional Chinese Medicine, Changshu, People's Republic of China.
Int J Nanomedicine. 2016 Jan 19;11:325-36. doi: 10.2147/IJN.S95540. eCollection 2016.
In this study, harmine liposomes (HM-lip) were prepared through the thin-film hydration-pH-gradient method and then coated with N-trimethyl chitosan (TMC). Particle size, zeta potential, entrapment efficiency, and in vitro release of HM-lip and TMC-coated harmine liposomes (TMC-HM-lip) were also determined. Sprague Dawley rats were further used to investigate the pharmacokinetics in vivo. Retention behavior in mouse gastrointestinal tract (GIT) was studied through high-performance liquid chromatography and near-infrared imaging. Degradation was further evaluated through incubation with Caco-2 cell homogenates, and a Caco-2 monolayer cell model was used to investigate the uptake and transport of drugs. HM-lip and TMC-HM-lip with particle size of 150-170 nm, an entrapment efficiency of about 81%, and a zeta potential of negative and positive, respectively, were prepared. The release of HM from HM-lip and TMC-HM-lip was slower than that from HM solution and was sensitive to pH. TMC-HM-lip exhibited higher oral bioavailability and had prolonged retention time in GIT. HM-lip and TMC-HM-lip could also protect HM against degradation in Caco-2 cell homogenates. The uptake amount of TMC-HM-lip was higher than that of HM and HM-lip. TMC-HM-lip further demonstrated higher apparent permeability coefficient (P(app)) from the apical to the basolateral side than HM and HM-lip because of its higher uptake and capability to open tight junctions in the cell monolayers. TMC-HM-lip can prolong the retention time in the GIT, protect HM against enzyme degradation, and improve transport across Caco-2 cell monolayers, thus enhancing the oral bioavailability of HM.
在本研究中,通过薄膜水化 - pH梯度法制备了 harmine 脂质体(HM-lip),然后用 N-三甲基壳聚糖(TMC)进行包衣。还测定了 HM-lip 和 TMC 包衣的 harmine 脂质体(TMC-HM-lip)的粒径、zeta 电位、包封率和体外释放情况。进一步使用 Sprague Dawley 大鼠研究其体内药代动力学。通过高效液相色谱和近红外成像研究了在小鼠胃肠道(GIT)中的滞留行为。通过与 Caco-2 细胞匀浆孵育进一步评估降解情况,并使用 Caco-2 单层细胞模型研究药物的摄取和转运。制备了粒径为 150 - 170 nm、包封率约为 81%、zeta 电位分别为负和正的 HM-lip 和 TMC-HM-lip。HM 从 HM-lip 和 TMC-HM-lip 中的释放比从 HM 溶液中释放慢,且对 pH 敏感。TMC-HM-lip 表现出更高的口服生物利用度,并且在 GIT 中的滞留时间延长。HM-lip 和 TMC-HM-lip 还可以保护 HM 免受 Caco-2 细胞匀浆的降解。TMC-HM-lip 的摄取量高于 HM 和 HM-lip。由于 TMC-HM-lip 具有更高的摄取能力和打开细胞单层紧密连接的能力,其从顶端到基底外侧的表观渗透系数(P(app))进一步高于 HM 和 HM-lip。TMC-HM-lip 可以延长在 GIT 中的滞留时间,保护 HM 免受酶降解,并改善跨 Caco-2 细胞单层的转运,从而提高 HM 的口服生物利用度。